论文部分内容阅读
使用溶栓剂——尿激酶(UK),溶解冠状动脉内血栓以治疗急性心肌梗塞(AMI)被认为是很有前途的一种治疗方法。我院心内科近年来使用UK治疗21例AMI,并对不同药物剂量及给药方法的疗效进行了观察,现将结果报道如下。临床资料 1.一般资料:21例患者全部男性,均符合WHO关于AMI的诊断标准,并符合下列条件:①年龄≤70岁;②发病时间≤12小时;③心电图ST段明显上抬;④胸痛持续30分钟以上且含服硝酸廿油无效;⑤无溶栓治疗禁忌症。给药同时进行心电监测,并制定冠脉再通指标:①胸痛突然缓解;②
The use of thrombolytic agent urokinase (UK) to dissolve coronary thrombus for the treatment of acute myocardial infarction (AMI) is considered a promising treatment. In recent years, our hospital cardiology use of UK treatment of 21 cases of AMI, and the efficacy of different drug doses and administration methods were observed, the results reported below. Clinical data 1. General information: All 21 patients with male, are in line with the WHO diagnostic criteria for AMI and meet the following conditions: ① age ≤ 70 years; ② onset time ≤ 12 hours; ③ ST segment elevation ECG; ④ chest pain Continued for more than 30 minutes and containing nitric oxide oil invalid; ⑤ no thrombolytic treatment contraindications. Administration of ECG while monitoring, and to develop indicators of coronary recanalization: ① sudden relief of chest pain; ②